Brentuximab Vedotin [brentuximab vedotin]
topical
42
- Terms
-
Adcetris
cAC10-vcMMAE
SGN-35
-
Adcetris
CAC10-1006
cAC10-vcMMAE
SGN-35
Persistent link
https://www.medvik.cz/link/D000079963
Definition
Immunoconjugate that consists of the chimeric monoclonal anti - CD30 ANTIGEN antibody cAC-10 conjugated to monomethyl auristatin E. It is used for the treatment of LYMPHOMA.
- DUI
- D000079963 MeSH Browser
- CUI
- M0551563
- History note
- 2020 (2010)
- Public note
- 2020; BRENTUXIMAB VEDOTIN was indexed under IMMUNOCONJUGATES 2010-2019
Allowable subheadings
- AD
- administration & dosage 6
- AE
- adverse effects 3
- AN
- analysis
- BI
- biosynthesis
- BL
- blood
- CF
- cerebrospinal fluid
- CH
- chemistry
- CL
- classification
- DE
- drug effects
- EC
- economics
- GE
- genetics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology 7
- PH
- physiology
- PO
- poisoning
- RE
- radiation effects
- TU
- therapeutic use 20
- TO
- toxicity 1
- UL
- ultrastructure
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D12.644.456.120
Antipain
D12.644.456.726
Peptichemio
D12.644.456.729
Peptide T
D12.644.456.810
Teprotide
D12.644.456.830
Tetragastrin